Untangling Depression, Antidepressant Use, and Symptom Severity: A Commentary on "The Association of Antidepressant Use and Impulse Control Disorder in Parkinson's Disease".

Authors :: Hitchins A
Schneider RB
Source :: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry [Am J Geriatr Psychiatry] 2024 Jun; Vol. 32 (6), pp. 721-723. Date of Electronic Publication: 2024 Jan 26.
Publication Year :: 2024
Abstract: Competing Interests: DISCLOSURES The authors have no conflicts of interest related to this manuscript. Dr. Hitchins reports no financial disclosures. Dr. Schneider reports research funding from NIH/NINDS, the Michael J. Fox Foundation for Parkinson's Research, Acadia Pharmaceuticals, Biohaven Pharmaceuticals, Bial, and CHDI Foundation. She also receives funding from Clintrex for participation on a DSMB.

Subjects :: Humans
Severity of Illness Index
Depression drug therapy
Parkinson Disease drug therapy
Parkinson Disease complications
Disruptive, Impulse Control, and Conduct Disorders chemically induced
Disruptive, Impulse Control, and Conduct Disorders drug therapy
Antidepressive Agents therapeutic use

Language :: English
ISSN :: 1545-7214
Volume :: 32
Issue :: 6
Database :: MEDLINE
Journal :: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
Publication Type :: Editorial & Opinion
Accession number :: 38311520
Full Text :: https://doi.org/10.1016/j.jagp.2024.01.028

Full Text Access

Tools